Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2017-2023
Historical Year
2024-2032
Forecast Year
Global Giant Cell Arteritis Treatment Market Outlook
The global giant cell arteritis treatment market was valued at USD 147.5 million in 2023, driven by increasing healthcare expenditure across the globe. It is expected to grow at a CAGR of 5.2% during the forecast period of 2024-2032, likely to reach a market value of USD 232.2 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America Market to be Aided by the Increasing Prevalence of the Disease.
North America holds a significant share in the global market for giant cell arteritis treatment. This can be correlated to the rising incidences of the disease among the patients. Apart from North America, Europe is also a key market for giant cell arteritis treatment. The European market is being driven by the higher standards of living and health awareness among the consumers in the region. Meanwhile, the Asia Pacific market is expected to witness a healthy growth in the coming years as well. The growing developments and technological advancements in the healthcare industry in countries such as India and China are aiding the market growth in the Asia Pacific region.
Giant Cell Arteritis: Market Segmentation
Giant cell arteritis (GCA), also known as temporal arteritis, is a disease of inflammation in large blood vessels, usually around the brain and head. Symptoms of GCA may include pain in the temples, flu, headache, double vision, and difficulty in opening the mouth. However, the causes of the disease are yet unknown.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the treatment type, the market is broadly classified into:
- Corticosteroid Therapy
- Others (Monoclonal Antibody)
By end-use, the market can be categorized into:
- Hospitals
- Clinics
- ASC’s
- Others
The EMR report looks into the regional markets of giant cell arteritis treatment like North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Elderly Population Driving the Market Growth of Giant Cell Arteritis Treatment
The increasing prevalence of giant cell arteritis across the globe is driving the market for giant cell arteritis treatment. It is generally observed in the elderly population. The increasing disposable incomes, coupled with the rising aged population, are aiding the market growth. The increasing health awareness and improving standards of living in developing countries are adding to the market growth. Governments across the globe are investing huge amounts in research and development activities in the healthcare sector. The subsequent technological advancements and developments in the healthcare industry are anticipated to provide an impetus for the growth of the market. These factors are expected to propel the global market for giant cell arteritis treatment forward over the forecast period.
Key Industry Players in the Global Giant Cell Arteritis Treatment Market
The report presents a detailed analysis of the following key players in the global giant cell arteritis treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- F. Hoffmann-La Roche Ltd.
- Kiniksa Pharmaceuticals, Ltd.
- Teva Pharmaceutical Industries Ltd.
- Tianjin Tianyao Pharmaceutical Co., Ltd.
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
View Our Best Selling Reports
Saudi Arabia Structural Steel Market
Europe Freeze-Dried Fruit Products Market
Saudi Arabia Electric Motors and Transformers Maintenance Market
Latin America Flexible Packaging Market
Giant Cell Arteritis Treatment Market Report Snapshots
Giant Cell Arteritis Treatment Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The global giant cell arteritis treatment market is expected to grow at a CAGR of 5.2%.
The major drivers of the industry, such as the increasing prevalence of the disease, rising disposable incomes, growing health consciousness, rapid urbanisation, and the growing elderly population, are expected to aid the market growth.
The key trend in the industry is the growing investments in the R&D activities of the healthcare sector.
The major regional markets for giant cell arteritis treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The major treatment types of giant cell arteritis in the market are corticosteroid therapy and others (monoclonal antibody).
The leading end use sectors for giant cell arteritis treatment in the market are hospitals, clinics, and ASC’s, among others.
The key players in the market include F. Hoffmann-La Roche Ltd., Kiniksa Pharmaceuticals, Ltd., Teva Pharmaceutical Industries Ltd., and Tianjin Tianyao Pharmaceutical Co., Ltd., among others.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124